PrecisionLife licenses OXEGENE dataset to develop personalized treatments for endometriosis

FHS
July 10, 2023
6:01 am

PrecisionLife, a leading techbio company driving precision medicine in complex chronic diseases, announced today a data access agreement with the University of Oxford to license the Oxford Endometriosis Gene (OXEGENE) dataset with the aim to develop new personalised treatments for endometriosis patients.

Psyence Group’s NASDAQ-Listed Associate, Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones | Psychedelic Invest

NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group“) (CSE: PSYG), a life science biotechnology company pioneering the use of nature-derived

September 18, 2024

Sanofi partners with Synthekine in immunology race

Synthekine is teaming up with Sanofi in a $40 million-plus collaboration to develop IL-10 receptor agonists for autoimmune and inflammatory diseases. The cytokine-focused biotech will

January 30, 2024

SPY ETF Analysis – what to expect next with SPY ETF as interest rates surge higher

June 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.